Prof. John Camm discusses dronedarone (Multaq) and vernakalant, new antiarrhythmic drugs for atrial fibrillation – Video
Posted on January 26th, 2010 by Mellanie
At Boston Atrial Fibrillation Symposium 2010, Prof. John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it.
See the video: Interview with Professor John Camm at Boston Atrial Fibrillation Symposium 2010




Discussion Area - Leave a Comment